Physical Medicine & Rehabilitation · Brownsville, TX
NPI
1720125412
Since 2007
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
315 Jose Marti Blvd
Brownsville, TX, 78526
Phone (956) 546-7530
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
4,991 services
Medicare patients, 2024
185
Average age 69
Drug cost, 2024
$199K
5,798 prescriptions
Company payments, 2025
$142
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Surya P Raguthu was code 97110 (pt treatment), 851 times for 54 patients. In total Surya P Raguthu billed 4,991 services in 56 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 97110 PT Treatment | Office | 851 | 54 | $16.94 | $14K |
| 99213 Office E&M - Established | Office | 767 | 147 | $65.76 | $50K |
| 97112 PT Treatment | Office | 483 | 52 | $25.34 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 413 | 30 | $0.09 | $37.39 |
| 97140 PT Treatment | Office | 388 | 44 | $15.96 | $6,193 |
| 96372 Injection Administration | Office | 364 | 103 | $10.65 | $3,878 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 223 | 86 | $5.37 | $1,198 |
| 95886 Electrical Nerve Conductivity | Office | 170 | 78 | $72.04 | $12K |
| 97035 PT Treatment | Office | 151 | 25 | $8.07 | $1,218 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 98 | 28 | $0.75 | $73.36 |
| 20611 Joint Injection | Office | 89 | 50 | $69.78 | $6,210 |
| 95911 Electrical Nerve Conductivity | Office | 86 | 78 | $158.48 | $14K |
| 76882 Ultrasound - Nonspecific | Office | 86 | 48 | $45.01 | $3,871 |
| 64494 Nerve Block Injection - Back | Office | 77 | 29 | $68.55 | $5,278 |
| 64493 Nerve Block Injection - Back | Office | 77 | 29 | $132.77 | $10K |
By year: 2022 $293K for 6,552 services; 2023 $251K for 6,148 services; 2024 $221K for 4,991 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 32 | 28 | $12.35 | $395 |
Medicare prescription drug claims, 2024
In 2024, the drug Surya P Raguthu prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,808 prescriptions and refills. In total Surya P Raguthu wrote 5,798 Medicare prescriptions that cost $199K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,808 | 1,808 | 257 | $75K |
| Naloxone Hcl Generic | 547 | 658 | 190 | $33K |
| Diclofenac Sodium Generic | 491 | 539 | 178 | $17K |
| Gabapentin Generic | 437 | 451 | 111 | $4,205 |
| Naproxen Generic | 425 | 425 | 142 | $4,704 |
| Tramadol Hcl Generic | 305 | 305 | 126 | $2,948 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 283 | 283 | 122 | $5,280 |
| Pregabalin Generic | 254 | 258 | 70 | $3,449 |
| Cyclobenzaprine Hcl Generic | 245 | 245 | 74 | $1,576 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 108 | 108 | 59 | $1,466 |
| Lidocaine Generic | 107 | 107 | 28 | $7,629 |
| Meloxicam Generic | 106 | 112 | 54 | $227 |
| Oxycodone Hcl Generic | 104 | 104 | 16 | $2,017 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 103 | 103 | 14 | $3,998 |
| Fentanyl Generic | 89 | 89 | 14 | $7,429 |
Brand drugs: - claims; generic drugs: 5,728 claims; opioid claims: 2,818.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Surya P Raguthu $142 ($142 in general payments such as food, travel and fees) from 3 companies. The largest payer was Globus Medical, Inc. with $62.2.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.